{"id":22254,"date":"2025-02-17T10:03:19","date_gmt":"2025-02-17T10:03:19","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/ai-act-linizio-di-una-nuova-era\/"},"modified":"2025-02-18T11:04:25","modified_gmt":"2025-02-18T11:04:25","slug":"ai-act-linizio-di-una-nuova-era","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/artificial-intelligence\/ai-act-linizio-di-una-nuova-era\/","title":{"rendered":"AI Act, the beginning of a new era"},"content":{"rendered":"

The AI \u200b\u200bAct, approved by the European Parliament on 13 March 2024 and published in the Official Journal of the EU as Regulation (EU) 2024\/1689<\/a>, represents the first comprehensive global legal framework on the regulation of artificial intelligence<\/strong>.<\/p>\n

Here’s what we’re talking about:<\/p>\n

AI Act, an epochal change<\/a>
\nClassification of AI systems and obligations<\/a>
\nFirst operational directives<\/a>
\nSistems at unacceptable risk<\/a>
\nMandatory training\u00a0<\/a>
\nThe other deadlines<\/a>
\nEuropean Commission guidelines<\/a>
\nSever penalties for violators<\/a>
\nWhat changes in Pharma sector<\/a>
\nStrategic opportunities<\/a>
\n<\/a><\/p>\n

AI Act, an epochal change<\/h2>\n

The AI Act marks a radical change for all companies <\/span> that use or develop artificial intelligence technologies<\/span>. The main objective of the legislation is to ensure the safety of European citizens, protect fundamental rights and promote the responsible development of these technologies<\/strong>, without hindering technological progress and innovation.<\/span><\/p>\n

Download the AI Act text<\/span><\/a><\/span><\/p>\n

The regulation concerns all companies that develop, distribute, import or use artificial intelligence systems within the European market. This includes:<\/span><\/p>\n